Plasmids Are Driving Antimicrobial Resistance Across Connected Reservoirs
Plasmid-mediated antimicrobial resistance now sits at the center of the One Health conversation because the same mobile genetic elements are moving between food-producing animals, retail foods, environmental waters and human clinical isolates. The review assembles genomic evidence showing that resistance is no longer best understood as a problem confined to one host species or one clinical setting. Instead, plasmids act as efficient vehicles for horizontal gene transfer, carrying determinants that reduce susceptibility to some of the most important antibiotic classes used in modern medicine.
A single resistant clone can matter, but a transferable plasmid can matter more when it crosses ecological boundaries. Once embedded in a successful plasmid backbone, a resistance gene can spread independently of bacterial lineage, seeding new hosts and new environments with far greater speed than clonal expansion alone would allow.
Why Horizontal Gene Transfer Changes the AMR Equation
Early surveillance efforts often focused on the spread of resistant bacterial clones, a useful approach when one strain dominates a ward, a farm, or a region. Genomic studies now show a broader pattern. Plasmid-mediated horizontal gene transfer has emerged as a major force shaping the global antimicrobial resistance landscape, moving resistance determinants through bacterial populations that are otherwise unrelated.
This matters because the same resistance gene can appear in different species, different compartments, and different countries while riding on related plasmid scaffolds. The review centers on key genes such as bla CTX-M, qnr, mcr, tet(X), and bla NDM, each tied to reduced susceptibility against critically important antimicrobials. Those include extended-spectrum β-lactams, quinolones, colistin, tigecycline and carbapenems. In clinical practice, each class failure narrows treatment options and increases the likelihood that empiric therapy will miss the organism until susceptibility data arrive.
Environmental compartments are not passive recipients in this process. Water systems, agricultural settings, food chains and human healthcare all provide selective pressure, and plasmids can persist when a bacterial host has a fitness advantage or when antibiotic exposure repeatedly favors maintenance of resistance genes. The review places these reservoirs on the same map rather than treating them as separate problems.
Key Resistance Genes Recur Across Food, Animals and Patients
The genomic literature synthesized in the review repeatedly identifies the same major resistance determinants across sectors. bla CTX-M remains especially important because it is linked to extended-spectrum β-lactam resistance and has become widely distributed in Enterobacterales from humans, animals and foods. The qnr family reduces quinolone susceptibility, while mcr genes threaten one of the last-line agents used against difficult Gram-negative infections by mediating colistin resistance. The appearance of tet(X) is clinically troubling because it compromises tigecycline, another drug often reserved for multidrug-resistant organisms. bla NDM carries even greater weight in the hospital setting because carbapenem resistance can leave few reliable therapeutic alternatives.
The important point is not simply that these genes exist. It is that they are being recovered in multiple niches and linked to plasmid backbones that can move across species barriers. In practical terms, a resistance problem found in a farm isolate can later reappear in a retail food sample, an environmental water specimen, or a human clinical isolate with little genetic distance separating the mobile element from one compartment to the next.
Successful Plasmids Outcompete Local Boundaries
Some plasmids spread better than others because their biology supports persistence, replication, and transfer in diverse hosts. The review emphasizes why certain plasmid backbones succeed across ecological niches: they are not tied to a single bacterial species, and they can carry multiple resistance genes while remaining stable enough to survive serial passage. Multi-resistance payloads increase the likelihood that one plasmid will be retained under different antibiotic pressures, whether those pressures arise in veterinary settings, food production, wastewater, or hospitals.
This mechanism explains why a single plasmid lineage can become disproportionately important. Once a backbone is well adapted to spread, the associated resistance genes gain a built-in dissemination route. The resulting pattern is broader than a standard outbreak because it is not bounded by one pathogen, one ward, or one country.
Surveillance strategies that only sample one sector will miss part of the story. Genomic tracking across the food chain, animal populations, human isolates and environmental reservoirs is necessary because the same mobile element may travel through several systems before it becomes visible in a clinical specimen.
Surveillance Must Follow the Mobile Element, Not Just the Organism
The review argues, through its synthesis of genomic evidence, that control efforts need to focus on the mobile genetic element as much as the bacterial host. This shift has direct implications for surveillance design. If monitoring only counts resistant species, public health teams may underestimate how often a resistance determinant is circulating silently on a plasmid that can later enter a pathogenic background.
A resistant organism is the visible end point. The plasmid often arrives first.
That distinction changes how outbreaks are interpreted and how prevention is organized. Food safety, veterinary stewardship, wastewater monitoring and hospital microbiology are all part of the same transmission network, and interventions in one compartment can be undermined if another compartment continues to select for the same plasmid. Genomic comparisons help identify whether similar resistance genes are linked to the same backbone or have entered a compartment through separate events, a difference that determines whether the problem is localized or structurally interconnected.
One Health Mitigation Depends on Genomic Resolution
The One Health framework remains the right lens because it matches the biology of the problem. Plasmid-mediated resistance does not respect the divisions between humans, animals and the environment, and the review makes clear that mitigation strategies must reflect that reality. Genomic surveillance can reveal which plasmids are circulating, which genes they carry, and how often related backbones appear across sectors. That information is essential for risk assessment, source tracing and policy design.
The clinical stakes are straightforward. When plasmids carrying carbapenem, colistin or extended-spectrum β-lactam resistance move through connected reservoirs, the downstream effect is fewer reliable treatment options for serious infections. In settings where empiric therapy already depends on broad-spectrum agents, continued spread of these mobile elements increases the odds of delayed active treatment and therapeutic failure.
This review does not introduce a new framework. It consolidates the genomic evidence already showing that plasmids are major vehicles of AMR dissemination across interconnected reservoirs. The unanswered practical issue is how quickly surveillance systems can be aligned across sectors well enough to detect these elements before they become embedded in both animal and human bacterial populations.